儿童SARS-CoV-2感染与围术期严重不良事件的多中心倾向评分分析
这项多中心回顾性队列研究纳入4534例接受全身麻醉的儿童,比较SARS-CoV-2感染(1138例)与非感染(3396例)患儿围术期严重不良事件风险;感染组风险显著升高(2.20% vs 0.80%,调整OR 2.34,95%CI 1.25-4.39),但感染组无心脏骤停、体外生命支持或死亡。
要点
- SARS-CoV-2感染患儿围术期严重不良事件风险约为非感染患儿的2.34倍
- 感染组严重不良事件发生率2.20%,非感染组0.80%
- 感染组无心脏骤停、体外生命支持或死亡病例
核心结论
- 儿童SARS-CoV-2感染与围术期严重不良事件风险升高相关,但感染组无死亡。
研究设计与样本
- 多中心(21家北美机构)回顾性队列研究,纳入<18岁、ASA PS 1-4级、非重症SARS-CoV-2感染且接受全身麻醉的儿童,麻醉日期为2020年4月1日至2021年3月31日。
- 采用倾向评分逆概率治疗加权多变量分析,将1138例麻醉前10天内SARS-CoV-2检测阳性患者与3396例非感染对照进行匹配。
主要发现
- 总样本4534例中52例发生严重不良事件(0.01%)。
- SARS-CoV-2感染组至少发生一次严重不良事件的风险高于非感染组(25/1138 [2.20%] vs 27/3396 [0.80%];调整OR 2.34;95%CI 1.25-4.39)。
- 感染组无儿童发生心脏骤停、需要体外生命支持或死亡。
关键数值与推荐
- 主要结局为麻醉后7天内严重围术期不良事件,包括因呼吸支持升级入住ICU、急性呼吸窘迫综合征、术后肺炎、心脏骤停、体外生命支持和死亡。
临床怎么用
- 对SARS-CoV-2感染儿童进行围术期风险评估时应考虑严重不良事件风险升高。
- 需结合感染时间(麻醉前10天内阳性)及ASA PS分级进行个体化决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidence of severe adverse events in children with SARS-CoV-2 undergoing anaesthesia has not been well established. We examined the relationship between SARS-CoV-2 infection and severe perioperative adverse events in children. METHODS: This multicentre (21 North American institutions), retrospective cohort study included children <18 years old, with American Society of Anesthesiologists physical status (ASA PS) of 1-4 and non-severe SARS-CoV-2, who underwent general anaesthesia between April 1, 2020, and March 31, 2021. The primary outcome was the incidence of severe perioperative adverse events (admission to the intensive care unit for escalation of respiratory support, acute respiratory distress syndrome, postoperative pneumonia, cardiovascular arrest, extracorporeal life support, and death) within 7 days of the anaesthetic, assessed using multivariable analysis with inverse probability of treatment weighting by the propensity score. A propensity score mixed-effects model included variables selected a priori. Inverse probability of treatment weighting was used to retain all data while balancing exposure groups on measured confounders. RESULTS: We matched 1138 patients with SARS-CoV-2 positive testing within 10 days of the anaesthetic to 3396 non-infected controls. The cohort included 56.6% (2568/4534) male patients, 69.9% (2839/4060) White patients, and 63.5% (2879/4533) ASA PS 1-2 patients. General surgery cases comprised 38.4% (1739/4534) of the cohort, followed by orthopaedic surgery at 12.6% (573/4534) and ear, nose, and throat surgery at 8.2% (371/4534). In the overall sample of 4534 patients, 52 had a severe adverse event (0.01%). Children with SARS-CoV-2 had a higher risk of at least one severe adverse event (25/1138 [2.20%] vs 27/3396 [0.80%] in those non-infected; adjusted odds ratio 2.34; 95% confidence interval 1.25-4.39). None of the children with SARS-CoV-2 had a cardiac arrest, required extracorporeal life support, or died. CONCLUSIONS: In the largest cohort to date of paediatric patients undergoing general anaesthesia, SARS-CoV-2 infection was associated with severe perioperative adverse events, but no children in the infected cohort died.
引用
- Saynhalath R, Sanford EL, Kato MA, et al. Multicentre analysis of severe perioperative adverse events in children undergoing surgery who were infected with SARS-CoV-2: a propensity score-adjusted analysis. Br J Anaesth. 2024. PMID: 39550319. doi:10.1016/j.bja.2024.10.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。